Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/08998280.2020.1754700 http://scihub22266oqcxt.onion/10.1080/08998280.2020.1754700 32336959!7171388!32336959     free     free     free Nephropedia Template TP {{tp|p=32336959|t=2020. SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill |pdf=|usr=}} gab.com Text SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill JO: Proc (Bayl Univ Med Cent) http://www.kidney.de/pget.php?&tw=1&pmid=32336959 #FOAvip The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread across the globe, and millions of people may be affected. While knowledge regarding epidemiologic features and diagnostic tools of coronavirus disease 2019 (COVID-19) is rapidly evolving, uncertainties surrounding various aspects of its optimal management strategies persist. A subset of these patients develop a more severe form of the disease characterized by expanding pulmonary lesions, sepsis, acute respiratory distress syndrome, and respiratory failure. Due to lack of data on treatment strategies specific to this subset of patients, currently available evidence on management of the critically ill needs to be extrapolated and customized to their clinical needs. The article calls attention to fluid stewardship in the critically ill with COVID-19 by judiciously applying the evidence-based resuscitation principles to their specific clinical features such as high rates of cardiac injury. As we await more data from treating these patients, this strategy is likely to help reduce potential complications. Twit Text FOAVip SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill 🦆🦆Proc (Bayl Univ Med Cent) http://www.kidney.de/pget.php?&tw=1&pmid=32336959 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32336959 #FOAvip English Wikipedia <ref>{{Cite pmid|32336959}}</ref> SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill #MMPMID32336959 Kazory A; Ronco C; McCullough PA Proc (Bayl Univ Med Cent) 2020[]; ä (ä): 1-6 PMID32336959show ga The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread across the globe, and millions of people may be affected. While knowledge regarding epidemiologic features and diagnostic tools of coronavirus disease 2019 (COVID-19) is rapidly evolving, uncertainties surrounding various aspects of its optimal management strategies persist. A subset of these patients develop a more severe form of the disease characterized by expanding pulmonary lesions, sepsis, acute respiratory distress syndrome, and respiratory failure. Due to lack of data on treatment strategies specific to this subset of patients, currently available evidence on management of the critically ill needs to be extrapolated and customized to their clinical needs. The article calls attention to fluid stewardship in the critically ill with COVID-19 by judiciously applying the evidence-based resuscitation principles to their specific clinical features such as high rates of cardiac injury. As we await more data from treating these patients, this strategy is likely to help reduce potential complications. äSARS-CoV-2 (COVID-19) and intravascular volume management strategies i(epmc).pdf DeepDyve Pubget Overpricing